Who owns Impax Laboratories?

Key details on Impax Laboratories (Ticker: IPXL)

Who owns Impax Laboratories?

Is IPXL a good stock to own? Find out who bought Impax Laboratories, who sold Impax Laboratories (IPXL) stock, and who holds a large position in Impax Laboratories.

Fund Name Number of Shares Share Valuation As Of
OrbiMed Advisors 6.78M $317.68M March 31, 2015
BlackRock Fund Advisors 5.31M $248.77M March 31, 2015
Vanguard 4.80M $225.24M March 31, 2015
Visium Asset Management 3.40M $52.50M March 31, 2013
Franklin Resources 3.35M $156.98M March 31, 2015
Inves 3.31M $104.73M Dec. 31, 2014
Wells Fargo & Company 2.71M $55.10M June 30, 2012
RS INVESTMENT MANAGEMENT 2.35M $59.09M Dec. 31, 2013
STATE STREET CORPORATION 2.30M $107.74M March 31, 2015
Wellington Management Company 2.23M $45.64M Dec. 31, 2012
Pennant Capital Management 2.02M $94.91M March 31, 2015
UBS GLOBAL ASSET MANAGEMENT AMERICAS 2.02M $94.77M March 31, 2015
FMR 1.87M $87.85M March 31, 2015
BlackRock Institutional Trust Company, N.A. 1.81M $84.70M March 31, 2015
Jennison Associates 1.72M $51.63M June 30, 2014
TCW 1.66M $42.96M Sept. 30, 2012
ALLIANCEBERNSTEIN 1.61M $32.97M Dec. 31, 2012
DIMENSIONAL FUND ADVISORS 1.60M $75.17M March 31, 2015
Ameriprise Financial 1.60M $50.58M Dec. 31, 2014
Apex Capital 1.49M $29.61M June 30, 2013
Ranger Investment Management 1.47M $30.22M Dec. 31, 2012
CITADEL ADVISORS 1.42M $29.19M Sept. 30, 2013

Who sold Impax Laboratories?

Fund Name Date Sold Number of Shares Sold Share Valuation
First Trust Advisors June 30, 2011 1.57M $34.19M
FRIESS ASSOCIATES March 31, 2011 2.19M $55.70M